| Secondary |
| Sleep Disorder |
25.0% |
| Hot Flush |
19.8% |
| Night Sweats |
16.7% |
| Weight Increased |
16.7% |
| Hormone Replacement Therapy |
8.3% |
| Migraine |
8.3% |
| Headache |
1.0% |
| Hypertension |
1.0% |
| Menopause |
1.0% |
| Obesity |
1.0% |
| Pure Hypercholesterolaemia |
1.0% |
|
| Night Sweats |
30.8% |
| Weight Increased |
30.8% |
| Drug Ineffective |
7.7% |
| International Normalised Ratio Decreased |
7.7% |
| Liver Function Test Abnormal |
7.7% |
| Pruritus |
7.7% |
| Sleep Disorder |
7.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.2% |
| Depression |
8.8% |
| Hypertension |
8.5% |
| Diabetes Mellitus |
5.8% |
| Drug Use For Unknown Indication |
5.8% |
| Osteoporosis |
4.9% |
| Breast Cancer |
4.6% |
| Pain |
4.2% |
| Hot Flush |
3.5% |
| Smoking Cessation Therapy |
3.5% |
| Bone Pain |
3.2% |
| Metastases To Bone |
3.0% |
| Blood Cholesterol Increased |
2.7% |
| Arthritis |
2.6% |
| Osteopenia |
2.6% |
| Migraine |
2.2% |
| Anxiety |
1.9% |
| Rheumatoid Arthritis |
1.9% |
| Crohn's Disease |
1.7% |
| Menopause |
1.7% |
|
| Vomiting |
17.2% |
| Wound Infection Staphylococcal |
8.6% |
| Lung Infiltration |
6.5% |
| Nausea |
6.5% |
| Vulvovaginal Pain |
6.5% |
| Hot Flush |
4.3% |
| Myocardial Infarction |
4.3% |
| Sleep Disorder |
4.3% |
| Transient Ischaemic Attack |
4.3% |
| Urticaria |
4.3% |
| Weight Increased |
4.3% |
| Anhedonia |
3.2% |
| Fatigue |
3.2% |
| Incisional Hernia |
3.2% |
| Insomnia |
3.2% |
| Metrorrhagia |
3.2% |
| Periorbital Haematoma |
3.2% |
| Pharmaceutical Product Complaint |
3.2% |
| Pruritus |
3.2% |
| Resorption Bone Increased |
3.2% |
|
| Interacting |
| Menopause |
25.0% |
| Smoking Cessation Therapy |
25.0% |
| Atrial Fibrillation |
12.5% |
| Depression |
12.5% |
| Hormone Replacement Therapy |
12.5% |
| Myocardial Infarction |
12.5% |
|
| Drug Interaction |
60.0% |
| General Physical Health Deterioration |
20.0% |
| International Normalised Ratio Decreased |
20.0% |
|
